A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEO-GLITIPNI). This is an ASCO Meeting Abstract ...
Clinical applications of urine- and blood-based genome wide copy number study from 1,000 patients with bladder and prostate cancer. The impact of blue light cystoscopy use among patients with ...
Visual Abstract. Active bowel inflammation disrupts the bowel cell lining, which causes the inflammatory T cells to secrete Granzyme B into the extracellular space, progressively accentuating the ...
Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...
Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT ...
image: 68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease. (A) Patient with high 68Ga-ABY-025 ...
FAPI PET/CT may be the better imaging tool to predict renal response to lupus nephritis induction therapy. For noninvasively predicting renal response to lupus nephritis induction therapy, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results